Press Releases

WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today provided an update on its $60 million manufacturing network optimization plan, a key initiative under its "execute" strategy. As part of ongoing efforts to enhance operational consistency and profitability, and

WILMINGTON, Del., June 24, 2025, – Ashland has launched additional viatel™ bioresorbable polymer grades with higher molecular weights and crystallinity that provide outstanding performance in medical device and dermal filler applications. This line extension is designed to expand our solution offering of lactide, glycolide and caprolactone copolymers for biomedical applications, specifically in the fabrication of degradable medical devices, regenerative medicine scaffolds and aesthetic medicine spaces.

Wilmington, Del., May 28, 2025 (GLOBE NEWSWIRE) -- Ashland will host an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility on May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology

WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter.

WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025.

Sales of $479 million, down 17 percent from the prior-year quarter Previously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively, “Portfolio Optimization”) reduced overall sales by approximately $67 million or 12

WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company’s live webcast with securities analysts will include an executive summary

Globalize strategy creates meaningful change for customers’ organic growth opportunities WILMINGTON, DE – April 3, 2025 – Ashland Global Holdings Inc. (NYSE: ASH) has launched collapeptyl™, a groundbreaking, biofunctional innovation in collagen science that addresses growing consumer demands for

WILMINGTON, Del., April 1, 2025 - In 2024 ASH celebrated 100-years of transformative change. Today, Ashland has laid the groundwork for a new kind of innovation, laser-focused on the future, driven by sustainable platform technologies and groundbreaking scientific discoveries.

Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing